197 related articles for article (PubMed ID: 22626820)
1. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.
Malik TH; Lavin PJ; Goicoechea de Jorge E; Vernon KA; Rose KL; Patel MP; de Leeuw M; Neary JJ; Conlon PJ; Winn MP; Pickering MC
J Am Soc Nephrol; 2012 Jul; 23(7):1155-60. PubMed ID: 22626820
[TBL] [Abstract][Full Text] [Related]
2. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
[TBL] [Abstract][Full Text] [Related]
3. Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese.
Xie J; Kiryluk K; Li Y; Mladkova N; Zhu L; Hou P; Ren H; Wang W; Zhang H; Chen N; Gharavi AG
J Am Soc Nephrol; 2016 Oct; 27(10):3187-3194. PubMed ID: 26940089
[TBL] [Abstract][Full Text] [Related]
4. Deletion Variants of
Jullien P; Laurent B; Claisse G; Masson I; Dinic M; Thibaudin D; Berthoux F; Alamartine E; Mariat C; Maillard N
J Am Soc Nephrol; 2018 Feb; 29(2):661-669. PubMed ID: 29114042
[TBL] [Abstract][Full Text] [Related]
5. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
[TBL] [Abstract][Full Text] [Related]
6. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
[TBL] [Abstract][Full Text] [Related]
7. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
[TBL] [Abstract][Full Text] [Related]
8. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
[TBL] [Abstract][Full Text] [Related]
9. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
[TBL] [Abstract][Full Text] [Related]
10. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
[TBL] [Abstract][Full Text] [Related]
11. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
[TBL] [Abstract][Full Text] [Related]
12. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
14. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
[TBL] [Abstract][Full Text] [Related]
15. Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.
Rogers LM; Mott SL; Smith BJ; Link BK; Sahin D; Weiner GJ
Clin Cancer Res; 2017 Feb; 23(4):954-961. PubMed ID: 27528699
[No Abstract] [Full Text] [Related]
16. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
Márquez-Tirado B; Gutiérrez-Tenorio J; Tortajada A; Lucientes Continente L; Caravaca-Fontán F; Malik TH; Roldán Montero R; Elías S; Saiz Gonzalez A; Fernández-Juarez G; Sánchez-Corral P; Pickering MC; Praga M; Rodríguez de Córdoba S; Goicoechea de Jorge E
J Am Soc Nephrol; 2022 Jun; 33(6):1137-1153. PubMed ID: 35545301
[TBL] [Abstract][Full Text] [Related]
17. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
18. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
Alic L; Papac-Milicevic N; Czamara D; Rudnick RB; Ozsvar-Kozma M; Hartmann A; Gurbisz M; Hoermann G; Haslinger-Hutter S; Zipfel PF; Skerka C; Binder EB; Binder CJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9942-9951. PubMed ID: 32321835
[TBL] [Abstract][Full Text] [Related]
20. Copy number variation analysis using next-generation sequencing identifies the
Park J; Yhim HY; Kang KP; Bae TW; Cho YG
Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
